Benign positive margins after radical prostatectomy means a poor prognosis--con.
Rubin
Mark A
MA
Montie
James E
JE
D000230:Adenocarcinoma / Q000097:blood / Q000175:diagnosis / Q000401:mortality / Q000473:pathology*; D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000097:blood; D015331:Cohort Studies; D005188:False Negative Reactions; D005189:False Positive Reactions; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009363:Neoplasm Proteins / Q000097:blood; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D016609:Neoplasms, Second Primary / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology; D011379:Prognosis; D011467:Prostate / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis / Q000401:mortality / Q000473:pathology*; D019564:Unnecessary Procedures
D015415:Biomarkers; D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D017430:Prostate-Specific Antigen